Resource center
Access the latest Clearwater resources to level up your investment strategies.
Private credit has been called a bubble, a black box, and the next 2008. It has also quietly become a core holding on some of the largest institutional balance sheets in the country. The headlines are loud and contradictory, but the data tells story of continued growth.
As the number of private equity-backed insurance companies has steadily increased in the past decade, so has the need for a solution that fits the specific needs of these organizations.
Asset managers, I’m here to tell you: It’s not a people problem. It’s a people + technology problem.
Investment regulatory reporting continues to grow more complex, it changes often, and it becomes even more complicated when firms have an international presence.
Would you like to get your quant research and ideas to market faster? Take a look at the Top 10 benefits of our platform and how they can accelerate your time to market.
Three NAIC working groups held meetings in February: The Risk-Based Capital (RBC) Investment Risk and Evaluation Working Group, the Valuation of Securities Task Force (VOSTF), and the Blanks Working Group (BWG). Many of the updates pertained to collateralized loan obligations (CLOs).
Catch up on all the important investment accounting updates from the NAIC’s Spring 2023 National Meeting.
With the recent award win for IFRS 9 Solution Provider of the Year, Clearwater has further established itself as the premier solution for regulatory reporting and compliance. For the past several years, Clearwater has provided industry expertise to businesses affected by IFRS 9. Now, Clearwater is being recognized for its standout service in the industry.
Organizations are facing unprecedented compliance challenges, but modern technology can help solve these problems. Read this article to learn the 5 best practices for compliance monitoring.
Watch this on-demand recording on Finance Transformation to learn how mREITs are leveraging technology with Clearwater Analytics and Chimera.